304 related articles for article (PubMed ID: 35456044)
1. Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.
Bonamonte D; Filoni A; De Marco A; Lospalluti L; Nacchiero E; Ronghi V; Colagrande A; Giudice G; Cazzato G
Cells; 2022 Apr; 11(8):. PubMed ID: 35456044
[TBL] [Abstract][Full Text] [Related]
2. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
Gayathri E; Anbukkarasi K; Lilly SM
Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
[TBL] [Abstract][Full Text] [Related]
3. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
[TBL] [Abstract][Full Text] [Related]
4. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
[TBL] [Abstract][Full Text] [Related]
5. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
[TBL] [Abstract][Full Text] [Related]
6. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
[TBL] [Abstract][Full Text] [Related]
7. Treatment of skin cancers in epidermolysis bullosa.
Venugopal SS; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):283-7, ix-x. PubMed ID: 20447493
[TBL] [Abstract][Full Text] [Related]
8. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
[TBL] [Abstract][Full Text] [Related]
9. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
Newman C; Wagner RF; Tyring SK; Spigel GT
J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
[TBL] [Abstract][Full Text] [Related]
11. Omaveloxolone attenuates squamous cell carcinoma growth and disease severity in an Epidermolysis Bullosa mouse model.
Cohen-Nowak AJ; Cohen AJ; Correia ED; Portocarrero CP; South AP; Nikbakht N
Exp Dermatol; 2022 Jul; 31(7):1083-1088. PubMed ID: 35285087
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center.
Retrosi C; Diociaiuti A; De Ranieri C; Corbeddu M; Carnevale C; Giancristoforo S; Marchili MR; Salvatori G; Atti MLCD; El Hachem M; Raponi M
Ital J Pediatr; 2022 Apr; 48(1):58. PubMed ID: 35414096
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
[TBL] [Abstract][Full Text] [Related]
15. Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa.
Trefzer L; Hess ME; Scholten L; Technau-Hafsi K; Meiss F; Boerries M; Has C; Rafei-Shamsabadi D
Acta Derm Venereol; 2023 Jun; 103():adv4870. PubMed ID: 37338146
[TBL] [Abstract][Full Text] [Related]
16. Surgical management and oncological follow-up of cutaneous squamous cell carcinomas arising in epidermolysis bullosa patients.
Paganelli A; Giordano E; Fiorentini C; Ferrari B; Reggiani C; Garbarino F; Magnoni C
Int J Dermatol; 2022 Oct; 61(10):1171-1174. PubMed ID: 35315931
[TBL] [Abstract][Full Text] [Related]
17. Epidermolysis bullosa and cancer.
Mallipeddi R
Clin Exp Dermatol; 2002 Nov; 27(8):616-23. PubMed ID: 12472531
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
[TBL] [Abstract][Full Text] [Related]
19. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
Intong LR; Murrell DF
Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
[TBL] [Abstract][Full Text] [Related]
20. The eye in epidermolysis bullosa.
Tong L; Hodgkins PR; Denyer J; Brosnahan D; Harper J; Russell-Eggitt I; Taylor DS; Atherton D
Br J Ophthalmol; 1999 Mar; 83(3):323-6. PubMed ID: 10365041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
